- Title: Subtitle
- Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study
- Creators
- Virginia ClarkCharlton StrangePavel StrnadAntonio SanchezPaul Yien KwoVítor Magno PereiraBart Van HoekIgor BarjaktarevicAngelo Guido CorsicoMonica PonsMonica GoldklangMeagan GrayBrooks KuhnHugo VargasJohn M. VierlingRaj VuppalanchiMark BrantlyNaomi KappeTing ChangThomas SchluepMin YiJames HamiltonJavier San MartinRohit Loomba
- Resource Type
- Abstract
- Publication Details
- Journal of hepatology, Vol.78, pp.S90-S91
- DOI
- 10.1016/S0168-8278(23)00573-1
- ISSN
- 0168-8278
- eISSN
- 1600-0641
- Language
- English
- Date published
- 06/2023
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9984459658602771
Abstract
Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study
Journal of hepatology, Vol.78, pp.S90-S91
06/2023
DOI: 10.1016/S0168-8278(23)00573-1
Details
Metrics
14 Record Views